[go: up one dir, main page]

GT199900019A - Formulas farmaceuticamente estables de solucion de oxaliplatino. - Google Patents

Formulas farmaceuticamente estables de solucion de oxaliplatino.

Info

Publication number
GT199900019A
GT199900019A GT199900019A GT199900019A GT199900019A GT 199900019 A GT199900019 A GT 199900019A GT 199900019 A GT199900019 A GT 199900019A GT 199900019 A GT199900019 A GT 199900019A GT 199900019 A GT199900019 A GT 199900019A
Authority
GT
Guatemala
Prior art keywords
oxaliplatino
solution
pharmaceutically stable
formulas
stable formulas
Prior art date
Application number
GT199900019A
Other languages
English (en)
Inventor
Nicholas H Anderson
Stephen Brown
David A England
Ross Blundell
Martin R Gray
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10827600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT199900019(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT199900019A publication Critical patent/GT199900019A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

LA INVENCIÒN SE RELACIONA CON FÒRMULAS FARMACEÙTICAMENTE ESTABLES DE SOLUCIÒN DE OXALIPLATINO, AL MÈTODO PARA USARLAS EN EL TRATAMIENTO DE TUMORES DE CÀNCER, A PROCESOS PARA LA PREPARACIÒN DE TALES FÒRMULAS Y A UN MÈTODO PARA ESTABILIZAR LAS SOLUCIONES DE OXALIPLATINO.
GT199900019A 1998-02-25 1999-02-11 Formulas farmaceuticamente estables de solucion de oxaliplatino. GT199900019A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9804013.2A GB9804013D0 (en) 1998-02-25 1998-02-25 Formulations

Publications (1)

Publication Number Publication Date
GT199900019A true GT199900019A (es) 2000-08-04

Family

ID=10827600

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900019A GT199900019A (es) 1998-02-25 1999-02-11 Formulas farmaceuticamente estables de solucion de oxaliplatino.

Country Status (27)

Country Link
US (1) US6306902B1 (es)
EP (1) EP0943331B1 (es)
JP (1) JP4430229B2 (es)
KR (1) KR20010041182A (es)
CN (1) CN1152718C (es)
AR (1) AR015524A1 (es)
AT (1) ATE202472T1 (es)
AU (1) AU757101B2 (es)
BR (1) BR9908273A (es)
CA (1) CA2261500C (es)
CZ (1) CZ302196B6 (es)
DE (1) DE69900162T2 (es)
DK (1) DK0943331T3 (es)
ES (1) ES2161085T3 (es)
GB (1) GB9804013D0 (es)
GR (1) GR3036646T3 (es)
GT (1) GT199900019A (es)
HU (1) HU224611B1 (es)
IL (1) IL137772A (es)
MX (1) MXPA00008195A (es)
NO (1) NO329900B1 (es)
PL (1) PL197948B1 (es)
PT (1) PT943331E (es)
RU (1) RU2207857C2 (es)
UA (1) UA70316C2 (es)
WO (1) WO1999043355A2 (es)
ZA (1) ZA991489B (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
WO2000021527A2 (fr) * 1998-10-14 2000-04-20 Debiopharm S.A. Conditionnement d'une preparation d'oxaliplatine
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
BRPI0013613B8 (pt) * 1999-08-30 2021-05-25 Debiopharm Sa composição farmacêuticamente estável de oxaliplatina para administração parenteral.
EP1341555A2 (fr) * 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
DE60220766T2 (de) 2001-03-02 2008-03-06 Debiopharm S.A. Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens
US20040186172A1 (en) 2001-07-02 2004-09-23 Houssam Ibrahim Oxaliplatin active substance with a very low content of oxalic acid
US6476068B1 (en) * 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
CA2388352A1 (en) * 2002-05-31 2003-11-30 Voiceage Corporation A method and device for frequency-selective pitch enhancement of synthesized speed
DE10314377A1 (de) * 2003-03-28 2004-10-07 Stada Arzneimittel Ag Gebrauchsfertige Oxaliplatin-Lösungen
US20050020556A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
GB2441445B (en) * 2003-08-28 2008-04-23 Mayne Pharma Ltd Acid containing oxaliplatin formulation
JP2007504098A (ja) 2003-08-28 2007-03-01 メイン・ファーマ・リミテッド 酸を含むオキサリプラチン製剤
CZ300795B6 (cs) * 2003-09-02 2009-08-12 Pliva-Lachema A. S. Farmaceutická kompozice a zpusob její výroby
JP2007504177A (ja) * 2003-09-02 2007-03-01 プリヴァ−ラケマ，エー．エス． 医薬組成物、その製造方法及び治療上の使用
EP2330110A1 (en) 2003-11-25 2011-06-08 Platco Technologies (Proprietary) Limited Platinum(II) complexes, preparation and use
WO2005056641A1 (ja) * 2003-12-10 2005-06-23 Toudai Tlo, Ltd. ジアミノシクロヘキサン白金(ii)とポリ(カルボン酸)セグメント含有ブロック共重合体との配位錯体、その抗腫瘍剤
CN100471493C (zh) * 2003-12-17 2009-03-25 梅比欧法姆股份有限公司 含有奥沙利铂的脂质体制剂
WO2005102312A1 (en) * 2004-04-27 2005-11-03 Mayne Pharma Limited Concentrated oxaliplatin solutions
PL1789427T3 (pl) 2004-09-01 2009-10-30 Platco Tech Proprietary Limited Otrzymywanie kompleksów platyny (II)
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
DE102004052877B4 (de) * 2004-11-02 2008-06-19 Ebewe Pharma Ges.M.B.H. Nfg.Kg Stabile wässrige Formulierungen eines Platin-Derivats
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
AU2005329764B2 (en) * 2005-03-28 2010-08-12 Dabur Pharma Ltd. Stable pharmaceutical compositions of platinum (II) antitumour agents
EP1874290A1 (en) * 2005-04-09 2008-01-09 Vuab Pharma A. S. A process for the preparation of an oxaliplatin preparation
RU2292210C1 (ru) * 2005-05-03 2007-01-27 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической цис-дихлородиамминплатины (ii)
DE102005038347A1 (de) * 2005-08-11 2007-02-15 Hexal Ag Herstellung einer Oxaliplatin-Lösung und Behälter sowie Behälter-Set mit der Lösung
WO2007029268A2 (en) * 2005-09-05 2007-03-15 Dabur Pharma Limited Stable oxaliplatin formulation
JP2009525273A (ja) 2006-01-30 2009-07-09 プラットコー テクノロジーズ （プロプライエタリー） リミテッド 白金（ｉｉ）錯体の調製
KR100913063B1 (ko) 2006-09-13 2009-08-21 주식회사유한양행 옥살리플라틴-함유 주사용 용액
MX2009007801A (es) * 2007-01-22 2009-10-08 Pliva Lachema As Composicion farmaceutica de oxaliplatino con regulador basado en azucar alcoholico.
RU2340347C2 (ru) * 2007-01-24 2008-12-10 Институт химии и химической технологии СО РАН (ИХХТ СО РАН) Способ получения стерилизованной микрокристаллической соли цис-дихлороамминизопропиламинплатины (ii)
US20100267824A1 (en) * 2007-11-12 2010-10-21 Intas Pharmaceuticals Limited Stable oxaliplatin composition for parenteral administration
US20090130017A1 (en) * 2007-11-19 2009-05-21 Searete Llc Targeted short-lived drug delivery
TW201021855A (en) * 2008-11-13 2010-06-16 Taigen Biotechnology Co Ltd Lyophilization formulation
CN101461801B (zh) * 2008-12-26 2013-05-15 辰欣药业股份有限公司 一种奥沙利铂药物组合物及其制备方法
AU2010296180B2 (en) 2009-09-21 2016-05-05 Bio-Synectics, Inc Oxaliplatin nanoparticles and method for preparing same
CN102274171A (zh) * 2011-08-04 2011-12-14 上海希迪制药有限公司 一种奥沙利铂注射剂
CN104523674B (zh) * 2014-12-11 2017-10-24 广州市上为医药科技有限公司 一种以奥沙利铂为主药成分的注射用组合物
KR101683635B1 (ko) * 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN104829653B (zh) * 2015-05-06 2016-03-23 山东罗欣药业集团股份有限公司 一种奥沙利铂水合物晶体及其冻干粉针剂
KR102868782B1 (ko) 2018-01-12 2025-10-13 (주)메티메디제약 만성 염증성 질환의 치료 방법

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6041077B2 (ja) * 1976-09-06 1985-09-13 喜徳 喜谷 １，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
PT93772A (pt) 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer
EP0464210A4 (en) 1989-12-15 1992-11-25 Tsumura & Co. Novel platinum complex and antitumor drug containing the same as active ingredient
JPH04185601A (ja) 1990-11-20 1992-07-02 Unitika Ltd 白金抗癌剤徐放性製剤
MX9206577A (es) 1991-11-15 1993-05-01 Smithkline Beecham Corp COMPOSICIóN FARMACEUTICA PARA INHIBIR EL CRECIMIENTO DE CELULAS TUMORALES
JPH0776230B2 (ja) * 1992-01-13 1995-08-16 田中貴金属工業株式会社 白金化合物の製造方法
JPH05238936A (ja) 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
JPH06287021A (ja) * 1992-04-22 1994-10-11 Tanaka Kikinzoku Kogyo Kk 光学活性な白金錯化合物の光学的分割方法
JP2673331B2 (ja) * 1993-01-12 1997-11-05 田中貴金属工業 株式会社 光学的に高純度なシス―オキザラート（トランス―１―１，２―シクロヘキサンジアミン）白金（▲ｉｉ▼）
AU5416394A (en) * 1992-11-24 1994-06-22 Debiopharm S.A. Cisplatinum/oxaliplatinum combination
JP3025602B2 (ja) * 1993-05-21 2000-03-27 デビオファーム エス．アー． 光学的に高純度なシス−オキザラート（トランス−ｌ−１，２−シクロヘキサンジアミン）白金（ＩＩ）錯体の製造方法
US5455270A (en) * 1993-08-11 1995-10-03 Bristol-Myers Squibb Co. Stabilized solutions of platinum(II) antitumor agents
KR100365171B1 (ko) 1994-08-08 2003-02-19 드바이오팜 에스.아. 약학적으로안정한옥살리플라티늄제제
DE69531722T2 (de) * 1994-11-11 2004-07-01 Debiopharm S.A. Karzinostatische Zusammensetzungen, welche Cis-Oxaliplatin und eine oder mehrere andere verträgliche Karzinostatika enthalten
FR2740686B1 (fr) * 1995-11-03 1998-01-16 Sanofi Sa Formulation pharmaceutique lyophilisee stable
EP0801070B1 (en) 1996-04-10 2003-04-16 Debiopharm S.A. Process of preparing platinum compound
JPH09294809A (ja) 1996-05-07 1997-11-18 Terumo Corp 薬液注入器具
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations

Also Published As

Publication number Publication date
ATE202472T1 (de) 2001-07-15
ZA991489B (en) 1999-09-30
CA2261500A1 (en) 1999-08-25
AR015524A1 (es) 2001-05-02
EP0943331B1 (en) 2001-06-27
RU2207857C2 (ru) 2003-07-10
MXPA00008195A (es) 2004-11-22
PL197948B1 (pl) 2008-05-30
CN1152718C (zh) 2004-06-09
NO20004240D0 (no) 2000-08-24
EP0943331A3 (en) 1999-11-03
EP0943331A2 (en) 1999-09-22
AU2632499A (en) 1999-09-15
WO1999043355A2 (en) 1999-09-02
CZ302196B6 (cs) 2010-12-15
WO1999043355A3 (en) 1999-11-04
PT943331E (pt) 2001-12-28
GR3036646T3 (en) 2001-12-31
CA2261500C (en) 2001-07-17
DE69900162D1 (de) 2001-08-02
HU224611B1 (hu) 2005-11-28
JP2002504524A (ja) 2002-02-12
PL343021A1 (en) 2001-07-30
CZ20003089A3 (cs) 2000-12-13
AU757101B2 (en) 2003-01-30
HUP0103707A3 (en) 2004-07-28
JP4430229B2 (ja) 2010-03-10
ES2161085T3 (es) 2001-11-16
UA70316C2 (uk) 2004-10-15
GB9804013D0 (en) 1998-04-22
NO20004240L (no) 2000-10-18
CN1291886A (zh) 2001-04-18
HK1036405A1 (en) 2002-01-04
DE69900162T2 (de) 2002-04-18
IL137772A (en) 2006-04-10
BR9908273A (pt) 2000-10-24
KR20010041182A (ko) 2001-05-15
DK0943331T3 (da) 2001-10-15
US6306902B1 (en) 2001-10-23
NO329900B1 (no) 2011-01-24
HUP0103707A2 (hu) 2002-02-28

Similar Documents

Publication Publication Date Title
GT199900019A (es) Formulas farmaceuticamente estables de solucion de oxaliplatino.
SE9504661D0 (sv) New compounds
EA200000274A2 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200001224A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
EA200000759A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
SE9904505D0 (sv) Novel compounds
BG63692B1 (bg) Производни на заместен 2-циклопентил-4-/4-флуорофенил/-7,7-диметил-тетрахидрохинолин и метод за получаването им
EA200100154A1 (ru) Бензоциклогептены, способ их получения, содержащие их фармацевтические препараты и их применение для получения лекарственных средств
BG106738A (en) A method for chemoprevention of prostate cancer
IS6658A (is) Ný efnasambönd
IS6520A (is) Ný efnasambönd
ES2136037B1 (es) Inhibidores de sulfamida-metaloproteasa
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
AR024138A1 (es) Inhibidores de la proliferacion celular
SE9900961D0 (sv) Novel compounds
SE9802208D0 (sv) Novel compounds
ATE238981T1 (de) Antitumorwirkstoffe
SE9804212D0 (sv) Compounds
ES2163197T3 (es) Procedimiento para producir ditiobis-alcanosulfonatos y fosfonatos.
EA200000996A1 (ru) Конденсированные с арилом азаполициклические соединения
DK1109560T3 (da) Som AICARFT-inhibitorer anvendelige forbindelser
TR200002203T2 (tr) Lemfotoksin (LT) sentezlenme yolunun inhibitörleri kullanılarak foliküler lemfomaların tedavisi.
ECSP034530A (es) Derivados de 6-metil-tramadol sustituido en o
ATE223721T1 (de) Edelfosin zur behandlung von hirntumoren